Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CVET | Common Stock | Options Exercise | $0 | +24.1K | +383.09% | $0.00 | 30.4K | May 13, 2021 | Direct | |
transaction | CVET | Common Stock | Sale | -$298K | -11.5K | -37.86% | $25.90 | 18.9K | May 14, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CVET | Restricted Stock Units | Options Exercise | $0 | -24.1K | -100% | $0.00* | 0 | May 13, 2021 | Common Stock | 24.1K | Direct | F2, F3 |
Id | Content |
---|---|
F1 | Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $25.84 - $26.03. The Reporting Person hereby undertakes, upon request by the Commission staff, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
F2 | Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock or the cash value thereof. |
F3 | Subject to the Reporting Person's continuous service as a director of the Issuer, 100% of the RSUs will vest on the first anniversary of the grant date. |